Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Aldoron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Haryana & Telangana Crack Down On Nimesulide Over 100 Mg
    Haryana & Telangana Crack Down On Nimesulide Over 100 Mg

    03 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183349&sid=1

    PHARMABIZ
    03 Jan 2026
    Share Share
    Government Bans Nimesulide Oral Formulations Above 100 mg
    Government Bans Nimesulide Oral Formulations Above 100 mg

    31 Dec 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/nimesulide-ban-govt-puts-a-stop-to-manufacture-sale-of-all-oral-formulations-containing-the-popular-painkiller-above-100-mg/articleshow/126263183.cms

    ECONOMICTIMES
    31 Dec 2025
    Share Share
    Nimesulide May Include Warning Label
    Nimesulide May Include Warning Label

    16 Sep 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nimesulide-may-come-with-warning-label/articleshow/123928117.cms

    ECONOMICTIMES
    16 Sep 2025
    Share Share
    ICMR for selective ban on popular painkiller
    ICMR for selective ban on popular painkiller

    23 Apr 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/icmr-for-selective-ban-on-popular-painkiller/articleshow/120529282.cms

    ECONOMICTIMES
    23 Apr 2025
    Share Share
    Helsinn and Angelini Pharma renew distribution deal
    Helsinn and Angelini Pharma renew distribution deal

    28 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/helsinn-angelini-distribution-deal/

    PHARMACEUTICAL TECHNOLOGY
    28 May 2024
    Share Share
    Brainfarma's Batch of Nimesulide Is Forbidden By Anvisa
    Brainfarma's Batch of Nimesulide Is Forbidden By Anvisa

    14 Aug 2017

    // ANVISA

    https://www.pharmacompass.com/pdf/news/brainfarmas-batch-of-nimesulide-is-forbidden-by-anvisa-1502939899.pdf

    ANVISA
    14 Aug 2017
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.